Development of a protective host response against intracellular pathogens requires innate and cell-mediated immune responses, with cytokines playing an important role in host defences. Different studies in mice have shown that IL-12 can promote protective immunity to a variety of viruses but, during virus infection, little is known about the in vivo function of IL-18 alone or in combination with IL-12. Using recombinant vaccinia viruses (rVVs) expressing IL-12 and IL-18, the antiviral role of both cytokines in mice has been analysed. The specific anti-VV immune response elicited and the persistence of the virus in target tissues were compared in BALB/c mice inoculated with rVVs expressing IL-12 and IL-18 either singly or in combination. Delivery of IL-12 and IL-18 by rVVs in mice induced a significant enhancement in virus clearance from ovaries and spleen, greater than that expected from the sum of action of both cytokines. Virus clearance involved NK and T cells, as demonstrated in mice depleted of NK cells and in immunodeficient SCID animals. Th1 parameters (CD8+ T cell response and IgG2a : IgG1 ratios) were increased in mice inoculated with rVVs expressing both IL-12 and IL-18 as compared to those animals receiving a single cytokine. These findings indicate that when IL-12 and IL-18 are delivered by rVVs, different mechanisms involving both the innate and specific arms of the immune system act as mediators in the synergistic action of IL-12 and IL-18, leading to VV clearance. These results are of interest for the design of prophylactic as well as therapeutic VV-based strategies.
BoelenA.,
KwakkelJ.,
BarendsM.,
de RondL.,
DormansJ.,
KimmanT.2002; Effect of lack of interleukin-4, interleukin-12, interleukin-18 or IFN- γ receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice. J Med Virol 66:552–560
BowieA.,
Kiss-TothE.,
SymonsJ. A.,
SmithG. L.,
DowerS. K.,
O'NeillL. A. J.2000; A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A 97:10162–10167
CoughlinC. M.,
SalhanyK. E.,
WysockaM.7 other authors1998; Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 101:1441–1452
DinarelloC. A.,
NovickD.,
PurenA. J.7 other authors1998; Overview of interleukin-18: more than an interferon- γ inducing factor. J Leukoc Biol 63:658–664
DybingJ. K.,
WaltersN.,
PascualD. W.1999; Role of endogenous IL-18 in resolving wild-type and attenuated Salmonella typhimurium infections. Infect Immun 67:6242–6248
GazzinelliR. T.,
GieseN. A.,
MooreH. C. R.III1994; In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J Exp Med 180:2199–2208
GherardiM. M.,
RamirezJ. C.,
RodriguezD.,
RodriguezJ. R.,
SanoG.,
ZavalaF.,
EstebanM.1999; IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner. J Immunol 162:6724–6733
GherardiM. M.,
RamírezJ. C.,
EstebanM.2001; Towards a new generation of vaccines: the cytokine IL-12 as an adjuvant to enhance cellular immune responses to pathogens during prime–booster vaccination regimens. Histol Histopathol 16:655–667
HarandiA. M.,
SvennerholmB.,
HolmgrenJ.,
ErikssonK.2001; Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J Virol 75:6705–6709
HofstraC. L.,
Van ArkI.,
HofmanG.,
KoolM.,
NijkampF. P.,
Van OosterhoutA. J. M.1998; Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 161:5054–5060
KimS. H.,
ReznikovL. L.,
StuytR. J. L.,
SelzmanC. H.,
FantuzziG.,
HoshinoT.,
YoungH. A.,
DinarelloC. A.2001; Functional reconstitution and regulation of IL-18 activity by the IL-18R β chain. J Immunol 166:148–154
KohnoK.,
KatakoaJ.,
OhtsukiT.,
SuemotoY.,
OkamotoI.,
UsuiM.,
IkedaM.,
KurimotoM.1997; IFN- γ -inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 158:1541–1550
LauwerysB. R.,
RenauldJ.-C.,
HoussiauF. A.1999; Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 11:822–830
LauwerysB. R.,
GarotN.,
RenauldJ.-C.,
HoussiauF. A.2000; Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15 or the combination of IL-12 and IL-18. J Immunol 165:1847–1853
MahalingamS.,
FarberJ. M.,
KarupiahG.1999; The interferon-inducible chemokines MuMig and Crg-2 exhibit antiviral activity in vivo
. J Virol 73:1479–1491
MicallefM. J.,
OhtsukiT.,
KohnoK.9 other authors1996; Interferon- γ -inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon- γ production. Eur J Immunol 26:1647–1651
MiyahiraY.,
MurataK.,
RodríguezD.,
RodríguezJ. R.,
EstebanM.,
RodriguesM. M.,
ZavalaF.1995; Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 181:45–54
MunderM.,
MalloM.,
EichmannK.,
ModolellM.1998; Murine macrophages secrete interferon- γ upon combined stimulation with interleukin (IL) 12 and IL-18: A novel pathway of autocrine macrophage activation. J Exp Med 187:2103–2108
OkamotoI.,
KohnoK.,
TanimotoT.,
IkegamiH.,
KurimotoM.1999; Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12. J Immunol 162:3202–3211
OrangeJ. S.,
BironC. A.1996; An absolute and restricted requirement for IL-12 in natural killer cell IFN- γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156:1138–1142
OrangeJ. S.,
WangB.,
TerhorstC.,
BironC. A.1995; Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182:1045–1056
QureshiM. H.,
ZhangT.,
KoguchiY.,
NakashimaK.,
OkamuraH.,
KurimotoM.,
KawakamiK.1999; Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans
. Eur J Immunol 29:643–649
RamírezJ. C.,
GherardiM. M.,
EstebanM.2000; The biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J Virol 74:923–933
RodríguezJ. F.,
RodríguezD.,
RodríguezJ. R.,
McGowanE. B.,
EstebanM.1988; Expression of the firefly luciferase gene in vaccinia virus: a highly sensitive gene marker to follow virus dissemination in tissues of infected animals. Proc Natl Acad Sci U S A 85:1667–1671
RodríguezJ. R.,
RiscoC.,
CarrascosaJ. L.,
EstebanM.,
RodríguezD.1997; Characterization of early stages in vaccinia virus membrane biogenesis: implications of the 21-kilodalton protein and a newly identified 15-kilodalton envelope protein. J Virol 71:1821–1833
SymonsJ. A.,
AdamsE.,
TscharkeD. C.,
ReadingP. C.,
WaldmannH.,
SmithG. L.2002; The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol 83:2833–2844
Tanaka-KataokaM. T.,
KunikataT.,
TakayamaS.,
IwakiK.,
OhashiK.,
IkedaM.,
KurimotoM.1999; In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection. Cytokine 11:593–599
TomuraM.,
MaruoS.,
MuJ.8 other authors1998; Differential capacities of CD4+, CD8+, and CD4−CD8− T cell subsets to express IL-18 receptor and produce IFN- γ in response to IL-18. J Immunol 160:3759–3765
van den BroekM.,
BachmannM. F.,
KöhlerG.,
BarnerM.,
EscherR.,
ZinkernagelR.,
KopfM.2000; IL-4 and IL-10 antagonize IL-12-mediated protection against acute vaccinia virus infection with a limited role of IFN- γ and nitric oxide synthetase 2. J Immunol 164:371–378
XiangY.,
MossB.1999; IL-18 binding and inhibition of interferon γ induction by human poxvirus-encoded proteins. Proc Natl Acad Science U S A 96:11537–11542
YamanakaK.,
HaraI.,
NagaiH.,
MiyakeH.,
GohjiK.,
MicallefM. J.,
KurimotoM.,
ArakawaS.,
KamidonoS.1999; Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model. Cancer Immunol Immunother 48:297–302
YoshimotoT.,
TakedaK.,
TanakaT. Ohkusu K.,
KashiwamuraS.,
OkamuraH.,
AkiraS.,
NakanishiK.1998; IL-12 upregulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN- γ production. J Immunol 161:3400–3407
ZhangY.,
WangY.,
GilmoreX.,
XuK.,
MbawuikeI. N.2001; Independent and synergistic effects of interleukin-18 and interleukin-12 in augmenting cytotoxic T lymphocyte responses and IFN- γ production in aging. J Interferon Cytokine Res 21:843–850